Importantly, dysregulated phosphorylation of synaptic CaMKII was reported at MCI stage of human AD [30], suggesting that reduced activity of synaptic CaMKII may indeed contribute to human disease. The gene discussed is CAMK2G; the disease is Alzheimer disease.